What have pharmacies paid for Valsartan since 2013?
What pharmacies pay, not what you pay. Valsartan has 4 products in the CMS NADAC survey, 4 products with year-end prices in more than one year. NADAC is what pharmacies pay to acquire a drug, not what a patient is charged. Valsartan 160 MG Tablet: $3.21 per unit at the 2014 survey and $0.106 at 2026 (−97%).
Not medical or financial advice. This page reports what pharmacies pay to acquire a drug, from the CMS NADAC survey. It is not what you will be charged, and it says nothing about which medicine is right for you. Ask your pharmacist or prescriber.
Valsartan4 products in NADAC
4products with a price history
Valsartan has 4 products in the CMS NADAC survey, 4 products with year-end prices in more than one year. NADAC is what pharmacies pay to acquire a drug, not what a patient is charged.
Between each product's first and latest year-end survey, 2 products cost pharmacies less and none costs more, by more than 5 percent, per unit as CMS states it.
2 of the changes rest on fewer than 3 priced NDCs at one end and are marked thin: a median over one or two NDCs reflects which NDCs were priced as much as a price movement.
This is a per-unit acquisition cost, not a retail price, a copay or an insurer's price, and it says nothing about why a price moved.
Valsartan 160 MG Tablet
Generic
$3.21 per unit at the 2014 year-end survey (3 NDCs) and $0.106 at the 2026 survey (18 NDCs): −97%.
year-end median across the NDCs pricedlowest to highest NDC
Year-end survey
Median per unit
Lowest to highest
NDCs priced
2014 (2014-12-31)
$3.21
3
2015 (2015-12-30)
$0.330
19
2016 (2016-12-28)
$0.197
20
2017 (2017-12-27)
$0.110
22
2018 (2018-12-26)
$0.370
17
2019 (2019-12-25)
$0.296
14
2020 (2020-12-30)
$0.271
14
2021 (2021-12-29)
$0.273
16
2022 (2022-12-28)
$0.232
16
2023 (2023-12-27)
$0.191
17
2024 (2024-12-25)
$0.150
19
2025 (2025-12-31)
$0.139
19
2026 (2026-11-11)
$0.106
18
Valsartan 320 MG Tablet
Generic
$4.02 per unit at the 2014 year-end survey (2 NDCs) and $0.170 at the 2026 survey (14 NDCs): −96%, a thin comparison.
year-end median across the NDCs pricedlowest to highest NDC
Year-end survey
Median per unit
Lowest to highest
NDCs priced
2014 (2014-12-31)
$4.02
2
2015 (2015-12-30)
$0.430
15
2016 (2016-12-28)
$0.308
18
2017 (2017-12-27)
$0.159
21
2018 (2018-12-26)
$0.395
16
2019 (2019-12-25)
$0.493
11
2020 (2020-12-30)
$0.389
11
2021 (2021-12-29)
$0.356
13
2022 (2022-12-28)
$0.265
14
2023 (2023-12-27)
$0.233
15
2024 (2024-12-25)
$0.197
16
2025 (2025-12-31)
$0.191
15
2026 (2026-11-11)
$0.170
14
Valsartan 40 MG Tablet
Generic
$2.52 per unit at the 2014 year-end survey (2 NDCs) and $0.100 at the 2026 survey (19 NDCs): −96%, a thin comparison.
year-end median across the NDCs pricedlowest to highest NDC
Year-end survey
Median per unit
Lowest to highest
NDCs priced
2014 (2014-12-31)
$2.52
2
2015 (2015-12-30)
$0.292
14
2016 (2016-12-28)
$0.179
16
2017 (2017-12-27)
$0.104
18
2018 (2018-12-26)
$0.260
14
2019 (2019-12-25)
$0.275
11
2020 (2020-12-30)
$0.247
11
2021 (2021-12-29)
$0.220
16
2022 (2022-12-28)
$0.162
17
2023 (2023-12-27)
$0.133
19
2024 (2024-12-25)
$0.123
20
2025 (2025-12-31)
$0.111
20
2026 (2026-11-11)
$0.100
19
Valsartan 80 MG Tablet
Generic
$3.01 per unit at the 2014 year-end survey (3 NDCs) and $0.081 at the 2026 survey (17 NDCs): −97%.
year-end median across the NDCs pricedlowest to highest NDC
Year-end survey
Median per unit
Lowest to highest
NDCs priced
2014 (2014-12-31)
$3.01
3
2015 (2015-12-30)
$0.320
18
2016 (2016-12-28)
$0.181
20
2017 (2017-12-27)
$0.090
24
2018 (2018-12-26)
$0.219
19
2019 (2019-12-25)
$0.266
14
2020 (2020-12-30)
$0.263
14
2021 (2021-12-29)
$0.233
16
2022 (2022-12-28)
$0.186
16
2023 (2023-12-27)
$0.155
17
2024 (2024-12-25)
$0.122
18
2025 (2025-12-31)
$0.124
18
2026 (2026-11-11)
$0.081
17
CMS National Average Drug Acquisition Cost, year-end surveys 2013 to 2026. A pharmacy acquisition cost, not a retail price. About NADAC.
Where does Valsartan sit on the generic price cliff?
Valsartan 160 MG Tablet: the first generic approval in its Orange Book group is dated 2014. Its year-end acquisition cost in 2026 is 3% of its first observed year-end price (2014). The median matched product, 12 years after its first generic approval, is at 16% (the middle half runs from 6% to 34%), so this product is below that middle half.
median of 200 matched productsmiddle halfeach productValsartan 160 MG Tablet
This is a pattern in matched products. It does not say the first generic caused the fall, and it does not say this product's price will follow the median. See it with other drugs.
How many companies make Valsartan?
The FDA Orange Book lists 16 generic makers as marketed in its largest dosage form for Valsartan, and the first generic approval is dated 26 June 2014. The acquisition costs above are what pharmacies pay across the NDCs priced; the Orange Book count is a separate record and this page does not say that more makers lowered a price. See each maker and the patents still listed on OmniRx.